
Team
Our management team, board and scientific advisory board have vast experience in the global pharma industry and provide a wealth of expertise.
Executive Leadership
Board of Directors
Strategic Advisory Council
The Nxera Strategic Advisory Council is an advisory body to provide strategic guidance and expert advice to the executive management of Nxera Pharma. The Council is composed of Japanese and international industry leaders, selected for their extensive international commercial, regulatory and government affairs, business development and operational experience in the pharmaceutical industry.
Dr. Paul Leeson
Paul is a medicinal chemistry consultant with >35 years’ experience in major pharmaceutical companies: Smith Kline and French, Merck Sharp and Dohme, Wyeth (USA), AstraZeneca, and GlaxoSmithKline. Since 2014 he has advised pharmaceutical companies, start-ups, and academia. Paul’s drug discovery contributions have been in the cardiovascular, neuroscience, respiratory and inflammation therapy areas. He has a special interest in compound quality and in 2014 he received the Nauta Award from the European Federation of Medicinal Chemistry. Paul has a PhD from the University of Cambridge and holds an honorary professorship at the University of Nottingham.